Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>Sapphire Foods Limited (SFL), one of Yum Brand’s franchisee in the Indian subcontinent, raised around US$280m in its Indian IPO.</li>
<li>Its core business is to operate KFC, Pizza Hut and Taco Bell in the Indian subcontinent.</li>
<li>In this note, we will talk about the subscription levels and the trading dynamics.</li>
</ul>


Sapphire Foods Limited (SFL), one of Yum Brand’s franchisee in the Indian subcontinent, raised around US$280m in its Indian IPO.
Its core business is to operate KFC, Pizza Hut and Taco Bell in the Indian subcontinent.
In this note, we will talk about the subscription levels and the trading dynamics.


Sapphire Foods IPO Trading - Demand Was So So, Peer Performance Might Help

APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

API Holdings Limited / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/api-holdings-limited" target="_blank" data-smartkarma-citation="entities:35071:1" rel="noopener">API Holdings Limited (1810068D IN)</a> is looking to raise US$843m in its India IPO. The deal will be run by Kotak, Morgan Stanley, Bank of America, Citigroup, and JM Financial.  </li>
<li>API Holdings, most known for its consumer healthcare super app, PharmEasy, is an amalgamation of a number of healthcare brands in India. </li>
<li>PharmEasy enables on-demand, home delivery of pharmaceutical products to consumers. As per RedSeer, it is India’s largest digital healthcare platform (based on GMV of products and services sold in FY21).</li>
</ul>



API Holdings Limited (1810068D IN) is looking to raise US$843m in its India IPO. The deal will be run by Kotak, Morgan Stanley, Bank of America, Citigroup, and JM Financial.  
API Holdings, most known for its consumer healthcare super app, PharmEasy, is an amalgamation of a number of healthcare brands in India. 
PharmEasy enables on-demand, home delivery of pharmaceutical products to consumers. As per RedSeer, it is India’s largest digital healthcare platform (based on GMV of products and services sold in FY21).


API Holdings (PharmEasy) Pre-IPO Tearsheet

<ul>
<li>Paytm (PAYTM IN) raised around US$2.5bn via selling a mix of primary and secondary shares in its India IPO.</li>
<li>The company is backed by <a href="https://www.smartkarma.com/entities/ant-group-co-ltd" target="_blank" data-smartkarma-citation="entities:24240:1" rel="noopener">Ant Financial Services Group (6688 HK)</a>, <a href="https://www.smartkarma.com/entities/softbank-group-corp" target="_blank" data-smartkarma-citation="entities:315:1" rel="noopener">Softbank Group (9984 JP)</a> and counts <a href="https://www.smartkarma.com/entities/berkshire-hathaway-inc-cl-a" target="_blank" data-smartkarma-citation="entities:1044:1" rel="noopener">Berkshire Hathaway Inc Cl A (BRK/A US)</a> among its investors.</li>
<li>In this note, we will talk about the subscription levels and the trading dynamics.</li>
</ul>


Paytm (PAYTM IN) raised around US$2.5bn via selling a mix of primary and secondary shares in its India IPO.
The company is backed by Ant Financial Services Group (6688 HK), Softbank Group (9984 JP) and counts Berkshire Hathaway Inc Cl A (BRK/A US) among its investors.
In this note, we will talk about the subscription levels and the trading dynamics.


Paytm IPO Trading - Largest IPO with Lowest Coverage, Skipped by Domestics

Lava International / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/lava-international" target="_blank" data-smartkarma-citation="entities:34998:1" rel="noopener">Lava International (9263793Z IN)</a> is looking to raise around US$188m in its upcoming India IPO. The deal will be run by Axis Capital, BOB Capital, DAM Capital, and SBI Capital.</li>
<li>Lava International is a mobile device manufacturer in India that covers the entire end-to-end process, from designing and manufacturing to distribution and servicing mobile handsets, tablets and other electronics accessories.</li>
<li>According to F&amp;S, the firm had a market share of 10.2% in the less than US$70 equivalent range market in India, in terms of sales volume in FY21.</li>
</ul>



Lava International (9263793Z IN) is looking to raise around US$188m in its upcoming India IPO. The deal will be run by Axis Capital, BOB Capital, DAM Capital, and SBI Capital.
Lava International is a mobile device manufacturer in India that covers the entire end-to-end process, from designing and manufacturing to distribution and servicing mobile handsets, tablets and other electronics accessories.
According to F&amp;S, the firm had a market share of 10.2% in the less than US$70 equivalent range market in India, in terms of sales volume in FY21.


Healthium Medtech / Equity Capital Markets

Healthium Medtech (HM) is looking to raise up to US$500m in its upcoming India IPO. Healthium Medtech is a global medtech company that manufactures products used in surgical, post-surgical and chronic care. It operates in three key markets namely, India, UK and the Rest of the World and currently has eight manufacturing facilities, seven in India and one in China. The firm has a diverse suite of offerings with over 52,000 SKUs and as of Mar 21, one in five surgeries conducted globally had used a Healthium Medtech product, as per Frost &amp; Sullivan (F&amp;S).While the company started off by manufacturing surgical consumables, it has since then expanded into other segments, mostly via acquisitions. Now the company primarily sells products pertaining to surgical consumables, urology and arthroscopy. HM revenue has been growing steadily over the past few years, while its margins have been expanding, resulting in bottom-line growth comfortably outpacing sales growth. In addition, HM has undertaken three acquisitions in FY22 which will increase its earnings by 40-50%. Although, the company hasn’t been very forthcoming with data and it didn’t pay a whole lot for the companies that it recently acquired.We have covered the company background in our earlier note, <a href="https://www.smartkarma.com/insights/healthium-medtech-pre-ipo-tearsheet" target="_blank" rel="noopener">Healthium Medtech Pre-IPO Tearsheet.</a>

Healthium Medtech (HM) is looking to raise up to US$500m in its upcoming India IPO. Healthium Medtech is a global medtech company that manufactures products used in surgical, post-surgical and chronic care. It operates in three key markets namely, India, UK and the Rest of the World and currently has eight manufacturing facilities, seven in India and one in China. The firm has a diverse suite of offerings with over 52,000 SKUs and as of Mar 21, one in five surgeries conducted globally had used a Healthium Medtech product, as per Frost &amp; Sullivan (F&amp;S).While the company started off by manufacturing surgical consumables, it has since then expanded into other segments, mostly via acquisitions. Now the company primarily sells products pertaining to surgical consumables, urology and arthroscopy. HM revenue has been growing steadily over the past few years, while its margins have been expanding, resulting in bottom-line growth comfortably outpacing sales growth. In addition, HM has undertaken three acquisitions in FY22 which will increase its earnings by 40-50%. Although, the company hasn’t been very forthcoming with data and it didn’t pay a whole lot for the companies that it recently acquired.We have covered the company background in our earlier note, Healthium Medtech Pre-IPO Tearsheet.

Healthium Medtech Pre-IPO - Steady Earnings, Creating a Niche

India

Zomato Limited is an online restaurant guide and food ordering platform. The Company offers platform connects customers, restaurant partners and delivery partners to search and discover restaurants, read and write customer generated reviews, order food delivery, book a table, and make payments while dining-out at restaurants. Zomato serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zomato (ZOMATO IN)

Sapphire Foods IPO Trading - Demand Was So So, Peer Performance Might Help

Sapphire Foods Limited (SFL), one of Yum Brand’s franchisee in the Indian subcontinent, raised around US$280m in its Indian IPO.

Sumeet Singh

API Holdings (PharmEasy) Pre-IPO Tearsheet

API Holdings Limited (1810068D IN) is looking to raise US$843m in its India IPO. The deal will be run by Kotak, Morgan Stanley, Bank of America,...

Clarence Chu

Paytm IPO Trading - Largest IPO with Lowest Coverage, Skipped by Domestics

Paytm (PAYTM IN) raised around US$2.5bn via selling a mix of primary and secondary shares in its India IPO. In this note, we will talk about the...

Sumeet Singh

Lava International Pre-IPO Tearsheet

Lava International (9263793Z IN) is looking to raise around US$188m in its upcoming India IPO. The deal will be run by Axis Capital, BOB Capital,...

Clarence Chu

Healthium Medtech Pre-IPO - Steady Earnings, Creating a Niche

Healthium Medtech is looking to raise up to US$500m in its upcoming India IPO. Healthium Medtech is a medtech company that manufactures products...

Sumeet Singh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)